Loading stock…

argenx SE (ARGX) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

ARGXargenx

Revenue FY25$4.2B

GROWTH RATING↗

VERY STRONG98 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+113%10

Revenue, next 1Y+48%10

Revenue, next 3Y, CAGR+30%10

Revenue, next 5Y, CAGR+25%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+41%9

EPS growth, FY27E+27%8

EPS growth, FY28E+31%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 98% of companies worldwide.

Revenue grew 113%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 30%/yr over the next 3 years, ahead of most of the market.10/10

The runway holds up: revenue is set to grow 25%/yr over five years.10/10

Earnings are set to grow in step with sales (EPS about 31%/yr vs revenue 30%/yr).

WATCH

Revenue grew 113%/yr over the last 3 years; forecasts see it cooling to 30%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

ARGXargenx

Total return Current1370%

Price return Current1370%

MOMENTUM RATING↗

STRONG69 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-8%3

3-month return+1%7

YTD return+10%6

MID & LONG-TERM▾SCORE

% of 52-week high87%7

1-year return+16%7

3-year return+87%7

5-year return+214%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +87% over three years and +214% over five, ahead of 70% of the market.

It's up 16% over the past year, but 13% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+1%).

WATCH

Returns sit at the market level so far this year (+10%).

WEAKNESSES

The stock is underperforming over the past month (-8%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming over the past month.

04Value

Are you paying a fair price for it?

Stop guessing on argenx. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

ARGXargenx

Revenue FY25$4.2B

GROWTH RATING↗

VERY STRONG98 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+113%10

Revenue, next 1Y+48%10

Revenue, next 3Y, CAGR+30%10

Revenue, next 5Y, CAGR+25%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+41%9

EPS growth, FY27E+27%8

EPS growth, FY28E+31%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 98% of companies worldwide.

Revenue grew 113%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 30%/yr over the next 3 years, ahead of most of the market.10/10

The runway holds up: revenue is set to grow 25%/yr over five years.10/10

Earnings are set to grow in step with sales (EPS about 31%/yr vs revenue 30%/yr).

WATCH

Revenue grew 113%/yr over the last 3 years; forecasts see it cooling to 30%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

ARGXargenx

Total return Current1370%

Price return Current1370%

MOMENTUM RATING↗

STRONG69 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-8%3

3-month return+1%7

YTD return+10%6

MID & LONG-TERM▾SCORE

% of 52-week high87%7

1-year return+16%7

3-year return+87%7

5-year return+214%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +87% over three years and +214% over five, ahead of 70% of the market.

It's up 16% over the past year, but 13% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+1%).

WATCH

Returns sit at the market level so far this year (+10%).

WEAKNESSES

The stock is underperforming over the past month (-8%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming over the past month.

04Value

Are you paying a fair price for it?

Stop guessing on argenx. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

argenx SE

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on argenx. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on argenx. Get the full investment case.

Premium